Sign In
Buy NVO
$47.64
+0.230 (+0.485%)
At Close: Jun 25, 2026
Novo Nordisk offers Wegovy for $199 for first month to new cash-paying customers
08:17am, Thursday, 22'nd May 2025
Novo Nordisk said on Thursday it is offering self-paying patients who are new to its weight loss drug Wegovy their first month of medicine for $199 through June 30.
With all doses of FDA-approved Wegovy® fully available nationwide, it is illegal under US compounding laws to make or sell knockoff "semaglutide" drugs, with rare exceptions New, one-time $199 first-
Focus: Novo Nordisk's former chief makes comeback to steer choice of new CEO
06:40am, Thursday, 22'nd May 2025
Years before Novo Nordisk's obesity drug Wegovy became a U.S. blockbuster, then-CEO Lars Rebien Sorensen told a press conference in Copenhagen: "You ain't seen nothing yet."
Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs
04:37pm, Wednesday, 21'st May 2025
Cigna's Evernorth unit said a new coverage deal with Eli Lilly and Novo Nordisk will bring lower copays for insured patients The company hopes the new discount, which caps monthly out-of-pocket costs
Novo Nordisk Foundation pledges $57 million to WHO amid US funding gap
12:35pm, Wednesday, 21'st May 2025
The Novo Nordisk Foundation has pledged up to DKK 380 million ($57.76 million) to the World Health Organization (WHO) to expand its tie-up with the United Nations agency for another four years, the ph
Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (May 2025)
07:55am, Wednesday, 21'st May 2025
Among all the weight loss drugs, Ozempic has become a phenomenon. With as much as $17 billion in sales in 2024, it shows no signs of slowing down, much to the delight of its Danish manufacturer, Novo
Why Novo Nordisk Stock Popped on Tuesday
12:40pm, Tuesday, 20'th May 2025
Novo Nordisk (NVO 1.98%) stock jumped 3% through 10:55 a.m. Tuesday on some potentially positive news in the GLP-1 weight loss market.
2 Fantastic Beaten-Down Growth Stocks Down 40% and 45% to Buy
10:53am, Tuesday, 20'th May 2025
In this video, I'll highlight two promising companies that could be great long-term investments, even in today's volatile market. Watch the short video to learn more, consider subscribing, and click t
Novo Nordisk Woes Weigh on Denmark's Economy. Here's How.
10:08am, Tuesday, 20'th May 2025
Denmark's economy contracted 0.5% in the first quarter of 2025, largely due to the pharmaceutical industry.
If I Could Only Buy 2 Dividend Stocks Right Now (May 2025 Edition)
07:30am, Tuesday, 20'th May 2025
I've added Novo Nordisk and Novartis to boost The Dividend Income Accelerator's healthcare allocation and global diversification, reducing overall risk and volatility. Both companies are attractively
Final Trade: NVO, TJX, XOM & DG
06:17pm, Monday, 19'th May 2025
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
Novo Nordisk is betting on a CEO shakeup to regain its weight loss drug edge over Eli Lilly
01:12pm, Monday, 19'th May 2025
Novo Nordisk is banking on fresh leadership to help it reclaim the crown in the booming weight loss drug market. The Danish drugmaker last week abruptly announced that longtime CEO Lars Fruergaard Jor
Novo Nordisk Shares Dip 3% on Sudden CEO Transition Announcement
11:15am, Monday, 19'th May 2025
NVO stock declines 3% as the company announces that Lars Fruergaard Jorgensen will be stepping down as the CEO.
Novo Nordisk announces CEO transition as share price slips
06:11am, Sunday, 18'th May 2025
Novo Nordisk announced Friday that it would part ways with its longtime CEO, who steered the company into an unprecedented boom time for weight-loss drugs.
35 Barron's Pro-Picks: One Ideal May DiviDog
04:51am, Sunday, 18'th May 2025
Barron's interviewed eleven financial industry Roundtable-pros who tapped 65 predictions. Six non-ADR foreign-stocks and four mutual funds were dropped by YCharts screens of active US listings, leavin
